Negar Almassi MPS[/caption]
Dr Brian Chia MPS[/caption]
COPD is significantly underdiagnosed
Associate Professor Debbie Rigby FPS[/caption]
Nicolette Ellis MPS[/caption]
A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
Both these disorders can occur separately, but if they co-occur, this is termed COMISA. Approximately 30–50% of people with OSA have comorbid insomnia, and 30–40% of people with chronic insomnia have comorbid OSA.9,12 A recent population-based study reported that 11% of Australian adults report symptoms of COMISA.13
The ‘gold standard’ measure of OSA presence and severity is an overnight sleep study (Table 1).25 The most common single metric to determine OSA presence and severity is the apnoea-hypopnoea index (AHI), representing the average number of airway narrowing and closure events occurring per hour of sleep.24 Identifying the most appropriate management approaches for OSA also requires consideration of lifestyle factors, symptoms and consequences, occupation, chronic conditions, and other sleep conditions. Self-report questionnaires may be used to screen for a high-risk of OSA and identify patients suitable for referral and consideration of overnight sleep study assessment (Table 1).24
Although evidence-based guidelines unanimously recommend avoiding long-term use of hypnotics, they are indicated for a minority of patients that present with severe acute insomnia that is causing significant psychological distress or functional impairment.29 Most people who experience short-term insomnia symptoms (1–2 weeks) can be reassured that sleep will return to ‘normal’ after the underlying precipitant has subsided, without targeted treatment (i.e. hypnotic medicines).29,33 For those who experience persistent insomnia, cognitive behavioural therapy for insomnia (CBTi) is the first-line treatment. Pharmacotherapy may be considered in patients with severe insomnia that is causing significant impairment or distress (e.g. times of acute work/exam stress, bereavement).34
Tailored recommendations for non-CPAP therapies may also be provided to patients with different levels of OSA severity and presenting features.17 For example, weight management advice where indicated, positional devices (in the presence of supine-predominant OSA), mandibular advancement splints (in patients with mild-to-moderate OSA), and upper airway surgery are effective treatments that may be tailored to each individual patient.24
Dr Alexander Sweetman (he/him) PhD
Senior Program Manager, and chair of the psychologist education subcommittee at the Australasian Sleep Association.
Associate Professor Sutapa Mukherjee (she/her) MBBS, FRACP, PhD
Respiratory and sleep physician, Associate Professor of Respiratory and Sleep Medicine at Flinders University and past President of the Australasian Sleep Association.
Professor Garun Hamilton (he/him) MBBS, FRACP, PhD
Respiratory and sleep physician, clinical professor at Monash Health and Monash University and President of the Australasian Sleep Association.
Professor John Turnidge AO[/caption]
Two in three Australians believe pharmacists should be able to administer commonly used vaccines that currently require a doctor’s appointment, new PSA research shows.
The nationwide poll by YouGov Galaxy found that 64 per cent of Australians support pharmacy administration of...
Submissions to the current Queensland Government inquiry into pharmacy ownership and regulation in the state have resoundingly supported current ownership provisions, amid concerns that any deregulation of current ownership laws would lead to the dilution of care.
There has been...
PSA18 has wrapped up in Sydney, with the future of pharmacy firmly in sight as PSA presented the Pharmacists in 2023 Discussion Paper, a five-year plan to realise the full potential of pharmacists.
PSA National President Dr Shane Jackson presented...
Researchers examining polypharmacy within aged populations have won the best paper and best poster categories at PSA18.
Lauren Corre and a team of University of South Australia researchers were awarded the PSA18 Best Poster Prize for their project,
Mapping medication...
I don’t feel like I can live off less money per month but I have heard of the importance of making additional super payments above the compulsory. Is it worth doing?
There will never be a good time to start...
University of Canberra’s Ben Coghlan has won the 2018 PSA Pharmacy Student of the Year (PSOTY) Award, announced at the PSA18 gala dinner last night in Sydney.
Mr Coghlan, who also won the PSOTY People’s Choice Award, is soon to...
PSA National President Dr Shane Jackson has used PSA18 to issue a call to arms for the future of pharmacy, illuminating a vision for the profession in which pharmacists’ greater role in healthcare is properly recognised and remunerated.
‘Now, more...
Recruitment is a perennial challenge for rural pharmacy. So what is being done to change this?
It will come as no surprise to many pharmacists to hear there’s a severe shortage of trained professionals to fill positions in rural and...
The shift from viewing pain as simply a symptom opens up opportunities to greatly improve the way it is treated, writes PainWISE MD Joyce McSwan MPS. How can pharmacists get behind it?
Pain science has changed.
For a very long time,...
Researchers in New Zealand have explored the perceived tension in pharmacy between their roles as retailers and healthcare providers, and how such tension is managed (if any).
In research published in the Journal of Pharmacy Practice and Research, Massey University...
